Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

Rhea-AI Summary

Collegium Pharmaceutical (Nasdaq: COLL) announced it will report its second quarter 2026 financial results before the U.S. market opens on Thursday, August 6, 2026. Immediately afterward, the company will host a live conference call and webcast at 8:00 a.m. ET to discuss the results.

Investors can join the call by dialing (877) 407-8037 in the U.S. or (201) 689-8037 internationally and referencing the “Collegium Pharmaceutical Q2 2026 Earnings Call.” A live and replay webcast will be available in the Investors section of www.collegiumpharma.com, with replay access beginning approximately two hours after the event.

News Market Reaction – COLL

+2.51%

+2.51% Session close to close

In the Jul 23 session, COLL gained 2.51%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Historical tag-specific context contains 2 prior earnings-date events, while this release only sched...

Analysis

Historical tag-specific context contains 2 prior earnings-date events, while this release only schedules disclosure. The small apples-to-apples sample adds context; insider context was Net Selling, and the August report is the key checkpoint.

Key Figures

Reporting period: Q2 2026 Report date: August 6, 2026 Conference call time: 8:00 a.m. ET +1 more

4 metrics

Reporting period Q2 2026 Financial results to be reported

Report date August 6, 2026 Before the market opens

Conference call time 8:00 a.m. ET Following the financial results release

Replay availability Approximately two hours After the event

Previous Earnings date Reports

2 past events · Latest: Apr 23 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 23	Earnings date	Neutral	-2.4%	Scheduled first-quarter results before the market opened on May 7, 2026
Feb 12	Earnings date	Neutral	+0.3%	Scheduled fourth-quarter and full-year results before the market opened

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two tag-specific earnings-date announcements produced mixed reactions, with an average move of -1.02%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STOUGHTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that it will report second quarter 2026 financial results before the market opens on Thursday August 6, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET.

Conference Call Information 
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q2 2026 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. Collegium has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions.

With a portfolio of differentiated ADHD medications, anchored by JORNAY PM^® (methylphenidate HCl) and AZSTARYS^® (serdexmethylphenidate and dexmethylphenidate), and an established leadership position in responsible pain management, Collegium leads with the scientific rigor and commercial expertise to deliver treatment options around how people live their lives. For more information, please visit collegiumpharma.com or find us on LinkedIn.

Investor Contact:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com

Media Contact:
Jessica Cotrone
Senior Vice President, Communications & Corporate Affairs
communications@collegiumpharma.com                                

FAQ

When will Collegium (NASDAQ: COLL) report its Q2 2026 financial results?

Collegium will report its Q2 2026 financial results on Thursday, August 6, 2026, before the U.S. market opens. According to Collegium, the release will be followed by a live earnings conference call and webcast that same morning.

What time is the Collegium Q2 2026 earnings conference call on August 6, 2026?

The Collegium Q2 2026 earnings conference call is scheduled for 8:00 a.m. ET on August 6, 2026. According to Collegium, the call will follow the earnings release and will be accessible by phone and webcast.

How can investors access the Collegium (COLL) Q2 2026 earnings call by phone?

Investors can access the Collegium Q2 2026 earnings call by dialing (877) 407-8037 in the U.S. or (201) 689-8037 internationally. According to Collegium, callers should reference the “Collegium Pharmaceutical Q2 2026 Earnings Call” to join.

Will there be a webcast and replay for the Collegium Q2 2026 earnings call?

Yes, Collegium will provide a live audio webcast of the Q2 2026 earnings call in the Investors section of www.collegiumpharma.com. According to Collegium, a replay will be available on the website approximately two hours after the event.

Where can shareholders find the Collegium Q2 2026 earnings webcast online?

Shareholders can find the Collegium Q2 2026 earnings webcast in the Investors section of www.collegiumpharma.com. According to Collegium, both the live webcast and an on-demand replay will be hosted on the company’s website.

What is the purpose of Collegium’s Q2 2026 earnings call for COLL investors?

The Q2 2026 earnings call allows Collegium to discuss its quarterly financial results with investors and analysts. According to Collegium, the call will follow the results release and be available via telephone and webcast for broader shareholder access.